Initially we used western blotting to evaluate the expression of Src, the overall level of SFK activation (using a Src Y416 phosphospecific antibody that cross-reacts with the analogous phosphotyrosine on other SFKs), and the downstream effector p120 catenin in a panel of GBM xenograft lines. Here, CTNND1 is linked to glioblastoma.